Poriya Ilit

This research aims to evaluate the safety and functional performance of the Nephronyx System in patients suffering from Acute Decompensated Heart Failure (ADHF) who show signs of excess fluid buildup and have a reduced response to diuretics. The study focuses on patients admitted to the hospital with ADHF and specific clinical criteria including heart function and blood markers. Participants will receive a temporary deployment of the Nephronyx System (Perfuser) device as the treatment under investigation. The study does not mention a control group or other interventions, focusing on assessing the device's procedural success and safety. During the study, researchers will monitor serious adverse events within 24 hours after device removal and evaluate the success of the procedure on the day it occurs. The study involves hospital monitoring and clinical assessments to measure outcomes related to safety and device performance.